ATE249224T1 - Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe - Google Patents

Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe

Info

Publication number
ATE249224T1
ATE249224T1 AT95923502T AT95923502T ATE249224T1 AT E249224 T1 ATE249224 T1 AT E249224T1 AT 95923502 T AT95923502 T AT 95923502T AT 95923502 T AT95923502 T AT 95923502T AT E249224 T1 ATE249224 T1 AT E249224T1
Authority
AT
Austria
Prior art keywords
amount
product containing
delayed release
medicinal product
release medicinal
Prior art date
Application number
AT95923502T
Other languages
English (en)
Inventor
Alan Patterson
Drew Holmes
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Application granted granted Critical
Publication of ATE249224T1 publication Critical patent/ATE249224T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95923502T 1994-07-09 1995-07-05 Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe ATE249224T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9413873A GB9413873D0 (en) 1994-07-09 1994-07-09 Long-acting oxytetracycline composition
PCT/GB1995/001583 WO1996001634A1 (en) 1994-07-09 1995-07-05 Long-acting oxytetracycline composition

Publications (1)

Publication Number Publication Date
ATE249224T1 true ATE249224T1 (de) 2003-09-15

Family

ID=10758078

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95923502T ATE249224T1 (de) 1994-07-09 1995-07-05 Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe

Country Status (13)

Country Link
EP (1) EP0769951B1 (de)
JP (2) JP4025925B2 (de)
CN (1) CN1081461C (de)
AT (1) ATE249224T1 (de)
AU (1) AU707366B2 (de)
DE (1) DE69531736T2 (de)
DK (1) DK0769951T3 (de)
ES (1) ES2204958T3 (de)
GB (1) GB9413873D0 (de)
MX (1) MX9700287A (de)
NZ (1) NZ288717A (de)
PT (1) PT769951E (de)
WO (1) WO1996001634A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US6479473B1 (en) * 1997-05-06 2002-11-12 Norbrook Laboratories Ltd. Long-acting antimicrobials
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
GB9928343D0 (en) * 1999-11-30 2000-01-26 Vericore Ltd Addition of tetracyclines to animal foodstuffs
US6428975B1 (en) 2000-01-14 2002-08-06 Blue Ridge Pharmaceuticals, Inc. Methods for determining the presence or absence of microorganisms in lipid-containing compositions
NO20014746D0 (no) 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
ES2315123B1 (es) * 2006-09-25 2009-12-30 Divasa-Farmavic, S.A. Composiciones farmaceuticas estables de tetraciclinas en solucion, procedimiento para su obtencion y sus usos.
ES2613738T3 (es) 2010-05-12 2017-05-25 Rempex Pharmaceuticals, Inc. Composiciones de tetraciclina
CN103271238B (zh) * 2013-05-10 2014-04-02 中国科学院亚热带农业生态研究所 一种饲料添加剂一乙醇胺的制备方法及应用
CN106309357A (zh) * 2016-11-08 2017-01-11 河南益华动物药业有限公司 兽用盐酸土霉素凝胶植入剂及其制备方法
CN110693826A (zh) * 2019-11-18 2020-01-17 成都新亨药业有限公司 一种兽用长效土霉素注射液及其制备方法
CN111035614B (zh) * 2019-12-20 2024-02-02 北京喜禽药业有限公司 一种高含量土霉素注射液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2034890B1 (de) * 1969-03-13 1974-05-24 Diamond Shamrock Corp
DE2001604C2 (de) * 1970-01-15 1983-04-14 Pfizer Gmbh, 7500 Karlsruhe Verwendung von Polyäthylenglykol zur Herstellung von Oxytetracyclinlösungen zur parenteralen, peroralen und lokalen Anwendung
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
CA1163197A (en) * 1980-04-10 1984-03-06 Herman Horn Injectable oxytetracycline compositions
NL178941C (nl) * 1982-06-15 1986-06-16 Aesculaap Bv Werkwijze voor de bereiding van een waterig oxytetracyclinepreparaat.
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5075295A (en) * 1989-12-12 1991-12-24 Boehringer Ingelheim Animal Health, Inc. Novel oxytetracycline compositions

Also Published As

Publication number Publication date
EP0769951A1 (de) 1997-05-02
MX9700287A (es) 1998-10-31
PT769951E (pt) 2003-12-31
JP4804431B2 (ja) 2011-11-02
JPH10502628A (ja) 1998-03-10
AU707366B2 (en) 1999-07-08
EP0769951B1 (de) 2003-09-10
CN1156963A (zh) 1997-08-13
JP2007326875A (ja) 2007-12-20
GB9413873D0 (en) 1994-08-31
CN1081461C (zh) 2002-03-27
DE69531736D1 (de) 2003-10-16
DK0769951T3 (da) 2004-01-12
NZ288717A (en) 1998-02-26
WO1996001634A1 (en) 1996-01-25
DE69531736T2 (de) 2004-07-08
AU2804395A (en) 1996-02-09
ES2204958T3 (es) 2004-05-01
JP4025925B2 (ja) 2007-12-26

Similar Documents

Publication Publication Date Title
EA200001154A1 (ru) Твердые композиции, содержащие производные гамма-аминомасляной кислоты, и способ их получения
ATE249224T1 (de) Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe
KR850007559A (ko) 조절 펩타이드의 삽입식 제형
LV10907A (lv) Interferona polietilenglikola atvasinajums
ES2173400T3 (es) Composiciones que contienen cinc para administracion oral que incluyen un compuesto de cobre y un aminoacido.
FI962111A (fi) Mikrokapseloidut 3-piperidinyyli-substituoidut 1,2-bentsisoksatsolit ja 1,2-bentsisotiatsolit
TW360544B (en) Analgestic and antiinflammatory fomentation pharmaceutical composition
ES2171933T3 (es) Derivados de androsteno.
ATE228005T1 (de) Pharmazeutische formulierungen aus corticotropin freisetzenden faktor mit verbesserter stabilitaet in fluessiger form
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
RU95100770A (ru) Противовоспалительные композиции местного применения, содержащие пироксикам, способ солюбилизации пироксикама
ES2028917T3 (es) Un procedimiento para preparar una composicion farmaceutica inyectable estable.
WO1996001634B1 (en) Long-acting oxytetracycline composition
JPS5651410A (en) Ointment
EP0647616A4 (de) Zink-tranexamat derivat.
FI962056A0 (fi) Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan
DE69824853D1 (de) Zusammensetzungen und gegenstände zur verminderung der auswirkung von entzündungen
CA2194576A1 (en) Long-acting oxytetracycline composition
JPS5750914A (en) Betamethasone external pharmaceutical
DE69708109T2 (de) Verfahren und zusammensetzungen zur steigerung der anaerobe leistungsfähigkeit in geweben
DE69804169T2 (de) Oral anzuwendende flüssige Arzneilösung
DE69121058T2 (de) Salze von Glykosaminoglykanen mit Aminosäureester, ihre Herstellung sowie sie enthaltende pharmazeutische Zusammensetzungen
IT1204778B (it) Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
Kinkead et al. Acute Oral and Dermal Toxicity of Ammnium Dinitramde (ADN)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0769951

Country of ref document: EP